These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7177261)

  • 21. [Therapeutic effects of chemotherapeutic regimen with pirarubicin for adult high-risk acute leukemia].
    Huang F; Meng FY; Xue B; Liu XL; Zhang Y; Ye CX; Zhang X
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Jul; 24(7):768-70. PubMed ID: 15257898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adriamycin combined with 10-day Ara-C, vincristine, and prednisone (10-day ADOAP) in the treatment of adult acute leukemia patients under fifty years of age. A Southwest Oncology Group Study.
    Schreiter SL; Amare M; Stuckey WJ; Oishi N; Saiki JH; Vial R; Pendleton O; Morrison FS
    Am J Clin Oncol; 1982 Dec; 5(6):641-3. PubMed ID: 7165007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Results of dose-intense, dose-impact weekly combination chemotherapy with rituximab for patients with CD 20-positive B-cell non-Hodgkin's lymphoma].
    Uzuka Y; Saitou Y; Saitou K; Suzuki S; Yamaguchi M
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1085-90. PubMed ID: 17637545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
    Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
    Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapeutic effects of chemotherapeutic regimens containing pirarubicin on the treatment of high-risk or refractory and relapsed acute leukemia in adults].
    Li QH; DU X; Huang ZL; Luo CW; Zhong LY; Lin W
    Zhonghua Yi Xue Za Zhi; 2005 May; 85(17):1195-7. PubMed ID: 16029595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Combined chemotherapy: prednisone, cytosine arabinose and vincristine in the treatment of acute non-lymphoblastic leukemia in the adult].
    Avilés-Miranda A; Monroy-Arellano LM; Conte-Lanza G; Morales-Polanco MR; Pizzuto-Chávez J
    Gac Med Mex; 1980 Aug; 116(8):359-64. PubMed ID: 7002697
    [No Abstract]   [Full Text] [Related]  

  • 27. [DCTP and DCMP two step therapy in acute non-lymphocytic leukemia (author's transl)].
    Morishima Y; Yamada K; Kawashima K; Ohno R; Ezaki K; Kodera Y; Kobayashi M; Takeyama H; Kato Y; Watanabe E; Suzuki H; Yamaguchi H; Tanimoto M; Minami S; Yokomaku S; Ogura M; Morishita T; Nishiwaki H; Yamada H; Ohara K; Yoshikawa S
    Rinsho Ketsueki; 1980 Jan; 21(1):33-8. PubMed ID: 7373867
    [No Abstract]   [Full Text] [Related]  

  • 28. Tailored therapy of adult acute leukaemia in Jehovah's Witnesses: unjustified reluctance to treat.
    Laszlo D; Agazzi A; Goldhirsch A; Cinieri S; Bertolini F; Rabascio C; Pruneri G; Calabrese L; Cocquio A; Martinelli G
    Eur J Haematol; 2004 Apr; 72(4):264-7. PubMed ID: 15089764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo cellular kinetic and pharmacological studies of 1-beta-D-arabinofuranosylcytosine and 3-deazauridine chemotherapy for relapsing acute leukemia.
    Barlogie B; Plunkett W; Raber M; Latreille J; Keating M; McCredie K
    Cancer Res; 1981 Mar; 41(3):1227-35. PubMed ID: 7459863
    [No Abstract]   [Full Text] [Related]  

  • 30. Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy.
    Liso V; Molica S; Capalbo S; Pogliani E; Battista C; Broccia G; Montillo M; Cuneo A; Leoni P; Specchia G; Castoldi G
    Haematologica; 2001 Nov; 86(11):1165-71. PubMed ID: 11694402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An unusual case of acute leukaemia.
    Pizzolo G; Chilosi M; Cetto G; Ambrosetti A; Perona G
    Haematologica; 1981 Aug; 66(4):489-92. PubMed ID: 6797882
    [No Abstract]   [Full Text] [Related]  

  • 32. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).
    Gobbi PG; Ghirardelli ML; Avanzini P; Baldini L; Quarta G; Stelitano C; Broglia C; Loni C; Silingardi V; Ascari E
    Haematologica; 2000 Mar; 85(3):263-8. PubMed ID: 10702814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimen.
    Weiser MA; O'Brien S; Thomas DA; Pierce SA; Lam TP; Kantarjian HM
    Cancer; 2002 Jan; 94(2):285-91. PubMed ID: 11900213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proliferation predicts failure-free survival in mantle cell lymphoma patients treated with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with rituximab plus high-dose methotrexate and cytarabine.
    Garcia M; Romaguera JE; Inamdar KV; Rassidakis GZ; Medeiros LJ
    Cancer; 2009 Mar; 115(5):1041-8. PubMed ID: 19170236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anthracyclines in the treatment of acute nonlymphocytic leukemias.
    Boiron M; Jacquillat C; Marty M; Weil M; Gisselbrecht C
    Cancer Treat Rep; 1981; 65 Suppl 4():73-6. PubMed ID: 6955013
    [No Abstract]   [Full Text] [Related]  

  • 36. Therapy for acute leukemia in adults with cytosine arabinoside (NSC-63878), vincristine (NSC-67574), and prednisone (NSC-10023).
    Burke PJ; Lenhard RE; Owens AH
    Cancer Chemother Rep; 1968 Feb; 52(2):305-14. PubMed ID: 5646858
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia.
    Kantarjian H; Thomas D; O'Brien S; Cortes J; Giles F; Jeha S; Bueso-Ramos CE; Pierce S; Shan J; Koller C; Beran M; Keating M; Freireich EJ
    Cancer; 2004 Dec; 101(12):2788-801. PubMed ID: 15481055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia: the Japan Adult Leukemia Study Group AML 97 Study.
    Miyawaki S; Sakamaki H; Ohtake S; Emi N; Yagasaki F; Mitani K; Matsuda S; Kishimoto Y; Miyazaki Y; Asou N; Matsushima T; Takahashi M; Ogawa Y; Honda S; Ohno R;
    Cancer; 2005 Dec; 104(12):2726-34. PubMed ID: 16284985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemotherapy of acute myeloblastic leukaemia with DAM regimen.
    Yunus AB; Sayeed MA; Barua A; Rahman J; Rashid MA
    Bangladesh Med Res Counc Bull; 1997 Dec; 23(3):82-6. PubMed ID: 9621477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design of controlled clinical trials: use of historical controls.
    Gehan EA
    Cancer Treat Rep; 1982 May; 66(5):1089-93. PubMed ID: 6211230
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.